NanoenTek Incorporated operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares NanoenTek Incorporated with three other
companies in this sector in South Korea:
iNtRON Biotechnology Inc
sales of 9.98 billion Korean Won [US$8.43 million]
of which 100%
was Genetic reagent division),
(16.66 billion Korean Won [US$14.07 million]
(17.85 billion Korean Won [US$15.09 million]
During the year ended December of 2014, sales at
NanoenTek Incorporated were 19.50 billion Korean Won (US$16.48 million).
increase of 2.2%
versus 2013, when the company's sales were 19.08 billion Korean Won.
This was the third consecutive year of growth at NanoenTek Incorporated.
Sales of Diagnosis saw an increase
that was more than double the company's growth rate: sales were up
102.1% in 2014, from
2.03 billion Korean Won to 4.11 billion Korean Won.
Not all segments of NanoenTek Incorporated experienced an increase in sales in 2014:
sales of Biotechnology fell 9.7% to 15.39 billion Korean Won.